Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like Bad loan resolution: Fixing a hole July 21, 2017 EXAIR introduces Gen4 Super Ion Air Wipe January 15, 2019 BorgWarner Swallows Delphi, Moves Aggressively into EV Space February 1, 2020